SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .: The Regulatory Body of South Korea Has Approved the Commercialisation of Yondelis for the of Soft Tissue Sarcoma .